Market Data Forecast recently published a report on the “North America Multiple Myeloma Therapeutics Market" which estimates the market to grow from USD 2.45billion from 2016 to USD 3.03 billion with a high CAGR of 4.37%. Learn details of the Treatment Type, by Drug Type and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
- Advertising -
Multiple Myeloma is a rare form of cancer caused due to malignant plasma cells. When plasma cells become cancerous, they produce a tumour called plasmacytoma.
If someone has more than one plasmacytoma, they have multiple myeloma. This is essentially a treatable cancer.
- Advertising -
The DROC Analysis contains some of the factors that have major effects on the market dynamics be it positive or negative. Few factors analysed in the section are increasing incidence of the disease cases, sustained success of revlimid and developing additional treatments.
Though, inflexible regulations by several governments impede the growth of North America multiple myeloma therapeutic market.
The market is segmented based on drug type and treatment type and studied for a deep-level understanding of the Multiple Myeloma therapeutics market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
- 1) By Treatment Type
- 2) By Drug Type
Arsenic trioxide (Trisenox)
North American Market is studied in geographic perspective by segregating the market shares between USA and Canada. USA is leading market for multiple myeloma therapeutics all over the globe and Canada is anticipated to grow at a high rate in the forecast period.
As per the report, some of the key contributors in the industry include AB Science SA, AbbVie Inc., Ablynx NV, Acceleron Pharma Inc., IGF Oncology LLC. , ImmunGene Inc., Millennium Pharmaceuticals Inc., MimiVax LLC, Mirna Therapeutics, RedHill Biopharma Ltd., Rhizen Pharmaceuticals S.A., Terpenoid Therapeutics Inc.
,Teva Pharmaceutical Industries Ltd. ,TG Therapeutics Inc. and Johnson and Johnson.
Scope of the North America Multiple Myeloma TherapeuticsMarket:
- Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the North American region
- To detect major focus areas of industrial growth Segment-level analysis on basis of type, therapeutics, end-user along with market size forecasts and y-o-y estimations are provided
- Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
- PESTLE and Porter’s Five Forces Analyses that examine the macro& micro environmental factors such as political influence, technological prowess, industry rivalry to name a few.
- An extensive listing of major market playersalong with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
- mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
- Expertly devised Market Outlook comprising theInvestment opportunitiesto provide both individuals and organizations a strong financial foothold in the market
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: